Search

everythinglearnresearchcommunity

for

Search:↓

Neoadjuvant chemotherapy followed by surgery leads to fewer severe complications and better quality of life than immediate surgery in advanced ovarian cancer patients with high tumor load.

Baricitinib is generally safe for long-term use in treating severe alopecia areata.

Baricitinib was effective in treating hair loss in adults with alopecia areata according to patient feedback.

Topical bexarotene 1% gel might help regrow hair in alopecia areata and is generally safe.

Weekly bicalutamide is safe and effective, with 50 mg/week recommended.

Sacituzumab govitecan improves quality of life and symptoms in breast cancer patients, except for causing more diarrhea.

Mirvetuximab soravtansine improves quality of life and reduces symptoms more than standard chemotherapy in ovarian cancer patients.

5% minoxidil foam is effective and safe for hair regrowth in women with hair loss.

Ritlecitinib effectively treats alopecia areata and is safe for long-term use in people 12 and older.

Pegylated liposomal doxorubicin is as effective as conventional doxorubicin but causes fewer heart problems and side effects.

The treatment combining docetaxel, cisplatin, and 5-FU is feasible and effective for advanced head and neck cancer.

Topical finasteride is an effective and safer treatment for male hair loss.

Neoadjuvant endocrine therapy led to a better future outlook than chemotherapy, with no major quality of life differences.

The new clinical trial design is promising but needs real-world trials to test its effectiveness and possible enhancements.

Baricitinib improved severe hair loss in adults over 52 weeks and was safe to use.

Testosterone patches can modestly improve sexual function in postmenopausal women not on estrogen therapy.

Hair regrowth from severe alopecia areata treatment with baricitinib can vary, with faster results in those with shorter hair loss duration.

Ustekinumab significantly improved sexual function and quality of life for people with moderate to severe psoriasis.

Once-daily 5% minoxidil foam and twice-daily 2% minoxidil solution are similarly effective and safe for female pattern hair loss.

Topical finasteride effectively and safely increases hair growth in men with hair loss.

The treatment showed high response rates and was well-tolerated, potentially extending patient survival.

Dutasteride 0.5 mg daily improves hair growth safely in men with hair loss.

DHEA treatment helps grow pubic hair and boosts mood in girls with adrenal issues.

Oral paclitaxel plus encequidar improved tumor response and caused less neuropathy but more serious infections than intravenous paclitaxel.

Cinainu is effective and safe for treating children's alopecia areata.

Low-dose dutasteride effectively and safely promotes hair growth in men.

DHEA therapy improved pubic hair growth and psychological well-being in young females with adrenal insufficiency.

DHEA therapy improves pubic hair growth and psychological well-being in girls with central adrenal insufficiency.

DHEA therapy improves pubic hair growth and psychological well-being in young females with central adrenal insufficiency.